Magali Richard
Founder at One Biosciences SAS
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David S. Schilansky | M | 48 |
Home Biosciences SAS
 Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception.
One Biosciences SAS
 One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France. | 13 years |
| Michel de Rosen | M | 73 | 6 years | |
| Daniel Tassé | M | 64 | 6 years | |
| Julie O'Neill | F | 58 | 7 years | |
| Isabelle Pelletier Bressac | F | - |
One Biosciences SAS
One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France. | - |
| Antoine Papiernik | M | 56 |
Home Biosciences SAS
Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception. | - |
| Pharis Mohideen | M | 59 | 5 years | |
| Hedi Brahim | M | 43 |
One Biosciences SAS
One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France. | 1 years |
| Caroline Daniere | F | 50 | 5 years | |
| Ming Fang | M | - |
Home Biosciences SAS
Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception. | - |
| Institut Curie | F | - |
One Biosciences SAS
One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pierre-Henri Benhamou | M | 69 | 17 years | |
| Laurent Martin | M | 57 | 12 years | |
| Susanna Mesa | F | 38 | 5 years | |
| Charles Ruban | M | 52 | 7 years | |
| Viviane Monges | F | 60 | 3 years | |
| Bertrand Dupont | M | 72 | 16 years | |
| Marina Dithurbide | F | 46 |
Ecole Polytechnique
| 4 years |
| Guillaume Hagège | M | - | - | |
| William de Wulf | M | 41 |
Ecole Polytechnique
| 3 years |
| Pierre-Hugues Paul Schmit | M | 46 |
Ecole Polytechnique
| 4 years |
| Céline Vallot | F | - |
One Biosciences SAS
One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France. | - |
| Alan Kerr | M | - | - | |
| Joe Becker | M | - | - | |
| Kevin Trapp | M | - | 2 years | |
| Joan Schmidt | F | 60 | 2 years | |
| Laurent Jumelle | M | - |
Ecole Polytechnique
| 3 years |
| Matthieu Muzumdar | M | - |
Ecole Polytechnique
| 3 years |
| Brice Masselot | M | - |
Ecole Polytechnique
| 3 years |
| Septien-Velez Septién | M | 62 | 3 years | |
| Geoffrey Bouquot | M | - |
Ecole Polytechnique
| 4 years |
| François Jean Glémet | M | - |
École Nationale Supérieure des Mines de Paris
| 5 years |
| Antoine Chiche | M | - |
Ecole Polytechnique
| 3 years |
| Charles-Hubert Le Baron | M | - |
École Nationale Supérieure des Mines de Paris
| 4 years |
| David Nicault | M | - |
Ecole Polytechnique
| 3 years |
| William X. de Wulf | M | - |
Ecole Polytechnique
| 3 years |
| Michael Krel | M | - |
Ecole Polytechnique
| 3 years |
| Olivier Laplenie | M | - |
Ecole Polytechnique
| 4 years |
| Liguori Jego | M | 45 |
Ecole Polytechnique
| 4 years |
| Pascal Levy-Garboua | M | - |
Ecole Polytechnique
| 3 years |
| Yves Barraquand | M | 64 |
Ecole Polytechnique
| 4 years |
| Rémi Said | M | - |
Ecole Polytechnique
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 42 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Magali Richard
- Personal Network
